Analysts Set Dyne Therapeutics, Inc. (NASDAQ:DYN) PT at $50.60
Dyne Therapeutics, Inc. (NASDAQ:DYN – Get Free Report) has been assigned an average rating of “Buy” from the ten analysts that are currently covering the stock, MarketBeat reports. Nine analysts have rated the stock with a buy recommendation and one has issued a strong buy recommendation on the company. The average 12 month target price […]
More Stories
Secret Service, Homeland Security Sued Over Records Related to Trump Assassination Attempt
By Jack Phillips A lawsuit was filed against the U.S. Secret Service and Department of Homeland Security (DHS) in a...
Trump Proposes Temporary 10 Percent Cap on Credit Card Interest Rates
By Andrew Moran Former President Donald Trump has proposed a 10 percent temporary cap on credit card interest rates, which...
A Particular Bacteria in Your Urine Can Help Protect Against Kidney Stones
By Rachel Ann T. Melegrito The urinary tract microbiome, also known as the urobiome, is home to various microorganisms. Researchers...
Cracker Barrel Old Country Store (NASDAQ:CBRL) Announces Earnings Results
Cracker Barrel Old Country Store (NASDAQ:CBRL – Get Free Report) released its quarterly earnings data on Thursday. The restaurant operator...
FedEx (NYSE:FDX) Posts Earnings Results, Misses Estimates By $1.22 EPS
FedEx (NYSE:FDX – Get Free Report) released its quarterly earnings data on Thursday. The shipping service provider reported $3.60 EPS...
Volta Finance (LON:VTA) Reaches New 1-Year High Following Dividend Announcement
Volta Finance Limited (LON:VTA – Get Free Report) reached a new 52-week high during trading on Thursday after the company...